Innospec Inc. (NASDAQ:IOSP) VP Philip John Boon Sells 3,754 Shares

Innospec Inc. (NASDAQ:IOSP) VP Philip John Boon sold 3,754 shares of Innospec stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $103.30, for a total transaction of $387,788.20. Following the sale, the vice president now owns 20,079 shares of the company’s stock, valued at approximately $2,074,160.70. The trade was a 15.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Innospec Stock Performance

Shares of IOSP opened at $104.38 on Wednesday. The firm has a market cap of $2.61 billion, a price-to-earnings ratio of 73.51 and a beta of 1.09. Innospec Inc. has a fifty-two week low of $99.49 and a fifty-two week high of $133.71. The firm has a 50 day moving average price of $110.41 and a 200-day moving average price of $112.37.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.05. The firm had revenue of $466.80 million during the quarter, compared to analyst estimates of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%. As a group, equities research analysts predict that Innospec Inc. will post 6.18 earnings per share for the current year.

Institutional Investors Weigh In On Innospec

A number of hedge funds have recently made changes to their positions in IOSP. Blue Trust Inc. lifted its holdings in shares of Innospec by 503.9% in the 3rd quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock worth $96,000 after acquiring an additional 650 shares during the last quarter. Raymond James & Associates raised its holdings in Innospec by 10.0% during the 3rd quarter. Raymond James & Associates now owns 83,843 shares of the specialty chemicals company’s stock valued at $9,482,000 after buying an additional 7,616 shares during the last quarter. New York State Teachers Retirement System raised its holdings in Innospec by 2.6% during the 3rd quarter. New York State Teachers Retirement System now owns 14,781 shares of the specialty chemicals company’s stock valued at $1,672,000 after buying an additional 371 shares during the last quarter. US Bancorp DE raised its holdings in Innospec by 323.6% during the 3rd quarter. US Bancorp DE now owns 5,490 shares of the specialty chemicals company’s stock valued at $621,000 after buying an additional 4,194 shares during the last quarter. Finally, Leeward Investments LLC MA raised its holdings in Innospec by 22.4% during the 3rd quarter. Leeward Investments LLC MA now owns 86,004 shares of the specialty chemicals company’s stock valued at $9,726,000 after buying an additional 15,750 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Innospec from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 11th.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.